How deadly is the coronavirus? Scientists are close to an answer

  title={How deadly is the coronavirus? Scientists are close to an answer},
  author={Smriti Mallapaty},
Public-health researchers use the infection fatality rate to gauge how to respond to a new disease, but it’s tricky to calculate. Public-health researchers use the infection fatality rate to gauge how to respond to a new disease, but it’s tricky to calculate. 

SARS‐CoV‐2 and COVID‐19 for the ophthalmologist

This review compiles general aspects of the novel coronavirus and COVID‐19, further dissects the most recent data on the role of the eye regarding disease transmission and manifestations, and summarizes preventive measures in the particular context of eye care.

COVID-19 and lombardy: TESTing the impact of the first wave of the pandemic

The effect of opening up the US on COVID-19 spread

It is shown that keeping NPIs just a few weeks longer has a substantial impact on the epidemic outcome, and a solution is found to measure mobility changes from mobile phone data and their impacts on the basic reproductive number.

A flexible COVID-19 model to assess mitigation, reopening, virus mutation and other changes

A discussion of a potential endemic end of COVID-19, which might involve times of about 100 years, is discussed, which ought to inform policy decisions around resource allocation, mitigation strategies and their duration, and economic tradeoffs.

Cannabidiol As a Treatment for COVID-19 Symptoms? A Critical Review.

There is not enough evidence to support or refute CBD as a repurpose drug to treat inflammation and other symptoms of COVID-19 and clinical trials are needed to test its efficacy and adverse effects.

[Seroprevalence and SARS-CoV-2 testing in healthcare occupations].

Although individual test results have to be interpreted with caution, serosurveillance in a tertiary eye care center and large eye research institute can reduce anxiety and provide clarity regarding the actual number of SARS-CoV‑2 infections.

COVID-19 and its Therapeutics: Special Emphasis on Mesenchymal Stem Cells Based Therapy

This compilation emphasizes Mesenchymal Stem Cells (MSCs) based therapy alone or in combination with other therapeutics as an attractive curative approach for COVID-19 pandemic.

A Novel Strategy for the Development of Vaccines for SARS-CoV-2 (COVID-19) and Other Viruses Using AI and Viral Shell Disorder

A novel strategy in attenuating viruses is suggested involving comparison of disorder patterns of inner shells of related viruses to identify residues and regions that could be ideal for mutation.

Brain and COVID-19 Crosstalk: Pathophysiological and Psychological Manifestations.

The neurological pathologies and psychological impact due to COVID-19, which has not only stressed the physical health of people but has also created social and economic problems resulting in mental health issues are discussed.

Public Health Lessons Learned From Biases in Coronavirus Mortality Overestimation

  • Ronald B. Brown
  • Medicine
    Disaster Medicine and Public Health Preparedness
  • 2020
Results of this critical appraisal reveal information bias and selection bias in coronavirus mortality overestimation, most likely caused by misclassifying an influenza infection fatality rate as a casefatality rate.



Infection fatality rate of SARS-CoV-2 infection in a German community with a super-spreading event

The number of infections in this high prevalence community is not representative for other parts of the world, but the IFR calculated on the basis of the infection rate in this community can be utilized to estimate the percentage of infected based on the number of reported fatalities in other places with similar population characteristics.

Estimating the infection and case fatality ratio for coronavirus disease (COVID-19) using age-adjusted data from the outbreak on the Diamond Princess cruise ship, February 2020

  • T. RussellJ. Hellewell A. Kucharski
  • Medicine
    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
  • 2020
Adjusting for delay from confirmation to death, case and infection fatality ratios (CFR, IFR) for coronavirus disease (COVID-19) on the Diamond Princess ship as 2.6% and 1.3% (95% confidence interval: 0.89–6.7) are estimated, respectively.

Remarkable variability in SARS-CoV-2 antibodies across Brazilian regions: nationwide serological household survey in 27 states

The first wave of seroprevalence surveys relying upon on household probabilistic samples of 133 large sentinel cities in Brazil suggest that pandemic is highly heterogenous, with rapid escalation in the North and Northeast, and slow progression in the South and Center-West regions.